Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to $36.16.Dividend yield and stable revenues prov ...

Historical patterns indicate that abrupt fluctuations in the market can impact any firm, regardless of its seeming dominance.

Pfizer 2025 earnings. That's the good news. The bad news is that while Pfizer "beat" on both sales and adjusted earnings, its ...

The company expects to launch more than 20 pivotal late-stage trials this year.

Pfizer's oncology ambitions could start to take shape next year. The drugmaker is also likely to make progress in the weight-loss market. It might take a while longer, but Pfizer is on the path to ...

In its upcoming report, Pfizer (PFE) is predicted by Wall Street analysts to post quarterly earnings of $0.57 per share, reflecting a decline of 9.5% compared to the same period last year. Revenues ...

Pfizer Inc. Buy: market overreacts to Q4 loss and 2026 guidance; oncology-led growth, 102-candidate pipeline, and dividend offer upside. Click for this PFE update.

Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...

What does a successful retirement look like? If it means financial security through steady income sources, then you can get there with the help of high-yield dividend stocks. Since retirement is ...